Curanex Pharmaceuticals Inc Common Stock (CURX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Curanex Pharmaceuticals Inc Common Stock (CURX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.7M, listed on NASDAQ, carrying a beta of -3.22 to the broader market. Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. Led by Jun Liu, public since 2025-08-26.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for CURX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →